BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37646815)

  • 1. An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values.
    Franco PN; Frade-Santos S; García-Baizán A; Paredes-Velázquez L; Aymerich M; Sironi S; Otero-García MM
    Eur Radiol; 2024 Mar; 34(3):1790-1803. PubMed ID: 37646815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Pecoraro M; Turkbey B; Purysko AS; Girometti R; Giannarini G; Villeirs G; Roberto M; Catalano C; Padhani AR; Barentsz JO; Panebianco V
    Radiology; 2022 Aug; 304(2):342-350. PubMed ID: 35536130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
    Panebianco V; Villeirs G; Weinreb JC; Turkbey BI; Margolis DJ; Richenberg J; Schoots IG; Moore CM; Futterer J; Macura KJ; Oto A; Bittencourt LK; Haider MA; Salomon G; Tempany CM; Padhani AR; Barentsz JO
    Eur Urol Oncol; 2021 Dec; 4(6):868-876. PubMed ID: 33582104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
    Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
    Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
    Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
    Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
    Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
    Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
    Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Application of the New Prostate Imaging for Recurrence Reporting (PI-RR) Score Proposed to Evaluate the Local Recurrence of Prostate Cancer after Radical Prostatectomy.
    Ciccarese F; Corcioni B; Bianchi L; De Cinque A; Paccapelo A; Galletta GL; Schiavina R; Brunocilla E; Golfieri R; Gaudiano C
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.
    Ke Z; Wang L; Min XD; Feng ZY; Kang Z; Zhang PP; Li BS; You HJ; Hou SC
    Chin Med J (Engl); 2018 Jul; 131(14):1666-1673. PubMed ID: 29998885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise.
    Bergaglio C; Giasotto V; Marcenaro M; Barra S; Turazzi M; Bauckneht M; Casaleggio A; Sciabà F; Terrone C; Mantica G; Borghesi M; Signori A; Spina B; Piol N; Zanardi E; Fornarini G; Zawaideh JP;
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres.
    Kohestani K; Wallström J; Dehlfors N; Sponga OM; Månsson M; Josefsson A; Carlsson S; Hellström M; Hugosson J
    Scand J Urol; 2019 Oct; 53(5):304-311. PubMed ID: 31661357
    [No Abstract]   [Full Text] [Related]  

  • 15. PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
    Abreu-Gomez J; Dias AB; Ghai S
    AJR Am J Roentgenol; 2023 Jun; 220(6):852-861. PubMed ID: 36722763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostate cancer local recurrence following radical prostatectomy: assessment using a continuously acquired radial golden-angle compressed sensing acquisition.
    Rosenkrantz AB; Khasgiwala A; Doshi AM; Ream JM; Taneja SS; Lepor H
    Abdom Radiol (NY); 2017 Jan; 42(1):290-297. PubMed ID: 27576605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
    Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
    Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy.
    Coppola A; Platania G; Ticca C; De Mattia C; Bortolato B; Palazzi MF; Vanzulli A
    Radiol Med; 2020 Jul; 125(7):683-690. PubMed ID: 32078119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
    AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.